(Q44578156)

4 December 2017

Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels (English)

1 reference

4 December 2017

Ross Grant

1

1 reference

PubMed ID

12963490

4 December 2017

Vimal Kapoor

series ordinal

2

1 reference

PubMed ID

12963490

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

Biochemical Pharmacology

1 reference

4 December 2017

66

1 reference

4 December 2017

6

1 reference

4 December 2017

1033-1036

1 reference

Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Metabolic coupling between glia and neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Activation by gamma interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased Km of the superoxide-generating NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Astrocytes in infectious and immune-mediated diseases of the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Activation of human macrophages. Comparison of other cytokines with interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Endogenous kynurenines as targets for drug discovery and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

An improved cycling assay for nicotinamide adenine dinucleotide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

Energy metabolism at the cellular level of the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900464-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(03)00464-7

1 reference

4 December 2017

1 reference

PubMed ID

12963490